Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Current Assets (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Current Assets for 15 consecutive years, with $31.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 2.14% year-over-year to $31.2 million, compared with a TTM value of $31.2 million through Sep 2025, down 2.14%, and an annual FY2024 reading of $33.3 million, up 75.24% over the prior year.
  • Current Assets was $31.2 million for Q3 2025 at Sanara MedTech, down from $33.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $36.8 million in Q1 2025 and bottomed at $17.2 million in Q1 2024.
  • Average Current Assets over 5 years is $25.1 million, with a median of $22.5 million recorded in 2022.
  • The sharpest move saw Current Assets soared 449.01% in 2021, then tumbled 31.44% in 2022.
  • Year by year, Current Assets stood at $24.6 million in 2021, then dropped by 16.22% to $20.6 million in 2022, then fell by 7.81% to $19.0 million in 2023, then skyrocketed by 75.24% to $33.3 million in 2024, then dropped by 6.25% to $31.2 million in 2025.
  • Business Quant data shows Current Assets for SMTI at $31.2 million in Q3 2025, $33.7 million in Q2 2025, and $36.8 million in Q1 2025.